Cannabis News and Research RSS Feed - Cannabis News and Research

Researchers find way to prevent, reduce or delay cannabis use amongst at-risk youth

Researchers find way to prevent, reduce or delay cannabis use amongst at-risk youth

Responding to rapidly shifting legal and cultural environments, researchers at the University of Montreal and CHU Sainte-Justine Children's Hospital have found a way to prevent, reduce or delay cannabis use amongst some at-risk youth. Cannabis users are at risk of neurocognitive deficits, reduced educational and occupational attainment, motor vehicle accidents, exacerbation of psychiatric symptoms, and precipitation of psychosis. [More]
Exposure to secondhand cannabis smoke causes mild intoxication

Exposure to secondhand cannabis smoke causes mild intoxication

Researchers recruited seven people ages 18 to 45 who said they smoked cannabis at least twice per week and tested positive for THC, but who tested negative for other drugs, and 12 others in the same age range who said they had not used cannabis in the past six months and tested negative for cannabis, other drugs, and alcohol... [More]
Secondhand exposure to cannabis smoke under extreme conditions impairs cognitive performance

Secondhand exposure to cannabis smoke under extreme conditions impairs cognitive performance

Secondhand exposure to cannabis smoke under "extreme conditions," such as an unventilated room or enclosed vehicle, can cause nonsmokers to feel the effects of the drug, have minor problems with memory and coordination, and in some cases test positive for the drug in a urinalysis. [More]
New Cannabis and Cannabinoid Research journal to be launched in fall 2015

New Cannabis and Cannabinoid Research journal to be launched in fall 2015

Cannabis and Cannabinoid Research, a new peer-reviewed, open access journal from Mary Ann Liebert, Inc., publishers, is the only journal dedicated to the scientific, medical, and psychosocial exploration of clinical cannabis, cannabinoids, and the biochemical mechanisms of endocannabinoids. [More]
Study: Cannabis consumers more prone to experiencing false memories

Study: Cannabis consumers more prone to experiencing false memories

​A new study published in the American journal with the highest impact factor in worldwide, Molecular Psychiatry, reveals that consumers of cannabis are more prone to experiencing false memories. [More]
Mott poll measures public's views about use of medical marijuana for children

Mott poll measures public's views about use of medical marijuana for children

Medical marijuana and children don't mix, most Americans say. While nearly two-thirds of people agree that their state should allow medical marijuana for adults, half as many - just over a third - say it should be allowed for children, according to today's University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health that included a national sample of adults in the U.S. [More]
ImmunoClin receives controlled drug license to supply, produce schedule 1 drugs in UK

ImmunoClin receives controlled drug license to supply, produce schedule 1 drugs in UK

ImmunoClin Corporation, a healthcare company specialized in personalized medicine, announces that its wholly owned subsidiary, ImmunoClin Ltd., received a controlled drug license from the UK government to possess, supply and produce schedule 1 drugs in its UK laboratory. [More]
DigiPath, Blue Line sign preferred supplier marketing and resource-sharing agreement

DigiPath, Blue Line sign preferred supplier marketing and resource-sharing agreement

DigiPath, Inc., the independent digital pathology and cannabis testing, education, and media firm, has entered into a preferred supplier marketing and resource-sharing agreement with Blue Line Protection Group. [More]
Cannabis use increases manic, depressive symptoms

Cannabis use increases manic, depressive symptoms

The first study to examine the use of cannabis in the context of daily life among people with Bipolar Disorder has shown how the drug is linked to increases in both manic and depressive symptoms. [More]
TNMNews examines how cannabis laws impact students, families

TNMNews examines how cannabis laws impact students, families

The latest segment of TNMNews, the unbiased marijuana talk radio program from DigiPath, Inc., focuses on how laws based on the War on Drugs have hurt students and families. [More]
CannTrust, Canabo to partner on medical marijuana research project

CannTrust, Canabo to partner on medical marijuana research project

CannTrust, Canada's only pharmacist-controlled licensed producer and distributor of medical cannabis today announced a collaboration with Canabo Medical Corporation to partner on a research project on marijuana for medical purposes. [More]
Cannabis abuse affects long-term memory, finds new Northwestern Medicine study

Cannabis abuse affects long-term memory, finds new Northwestern Medicine study

Teens who were heavy marijuana users - smoking it daily for about three years -- had an abnormally shaped hippocampus and performed poorly on long-term memory tasks, reports a new Northwestern Medicine study. [More]
One World Cannabis, Sheba Academic Medical Center ink collaboration agreement

One World Cannabis, Sheba Academic Medical Center ink collaboration agreement

OWC Pharmaceutical Research Corp.'s wholly owned subsidiary One World Cannabis Ltd. signed a collaboration agreement with Sheba Academic Medical Center, the largest hospital in Israel and in the Middle East. [More]
InMed, University of Debrecen partner to develop novel therapies to treat ocular allergies

InMed, University of Debrecen partner to develop novel therapies to treat ocular allergies

InMed Pharmaceuticals Inc. announces it has formed an exclusive strategic collaboration with the University of Debrecen, Hungary, to develop novel phytocannabinoid-based therapies to treat ocular allergic symptoms. [More]
Researchers develop robust screening method for routine measurement of drugs in exhaled breath

Researchers develop robust screening method for routine measurement of drugs in exhaled breath

Drug testing is most commonly performed using urine samples. The methodology and regulations for reliable urine testing are well developed and can be considered the current gold standard for drug testing. [More]
Study demonstrates that activation of cannabinoid CB2 receptors suppresses chronic pain

Study demonstrates that activation of cannabinoid CB2 receptors suppresses chronic pain

Medical marijuana is proliferating across the country due to the ability of cannabis ingestion to treat important clinical problems such as chronic pain. However, negative side effects and the development of tolerance limit the widespread therapeutic use of Δ9-tetrahydrocannabinol (Δ9-THC), the major psychoactive ingredient in cannabis. [More]
New article shows how marijuana can act as an allergen

New article shows how marijuana can act as an allergen

Growing up, you may have been given reasons for not smoking marijuana. What you may not have heard is that marijuana, like other pollen-bearing plants, is an allergen which can cause allergic responses. [More]
Steep Hill plans to open laboratory for testing quality of medical cannabis

Steep Hill plans to open laboratory for testing quality of medical cannabis

Steep Hill, the industry leader in cannabis testing and analytics in the US and internationally, intends to open a full service medical cannabis quality assurance laboratory in Albuquerque, New Mexico, bringing advanced scientific tools and methodology to the state, for regulatory oversight of cannabis. [More]
LSU Health New Orleans finalizes deal with CB BioSciences

LSU Health New Orleans finalizes deal with CB BioSciences

The Office of Technology Management at LSU Health New Orleans has finalized a deal with CB BioSciences, Inc., a startup drug development company to build a platform around the intellectual property portfolio of Chu Chen, PhD, LSU Health New Orleans Professor of Neuroscience. [More]

CannTrust receives Health Canada approval to produce, distribute medical cannabis in Canada

CannTrust Inc., a privately held, wholly-owned Canadian company, has been approved by Health Canada as a Licensed Producer and distributor of medical cannabis in Canada, under the Marihuana for Medical Purposes Regulations. [More]
Advertisement
Advertisement